Generic Drugs Summit Main Conference Day 1

Have a question about this event?
Customer Service representatives are available to help from 8 AM - 6 PM EST
Call 888-670-8200

Need Technical Assistance With this Website?
Send an email to IIR's Web Department

Home»Events»Generic Drugs Summit Event Overview»Main Conference Day One

Generic Drugs Summit

June 18 - 20, 2008 | Ritz Carlton, Washington, DC

Main Conference Day One

Thursday, June 19, 2008

7:00	Registration and Morning Coffee
8:00	Chairpersons Opening Remarks Shashank Upadhye, Esq. Vice President - Global Head of Intellectual Property APOTEX, INC.
8:15	CONGRESSIONAL ADDRESS: Update on Hatch-Waxman Reform Representative Henry A. Waxman, MEMBER OF CONGRESS, UNITED STATES, 30TH DISTRICT OF CALIFORNIA
9:00	The Follow-On Biologics Struggle Continues: The 2008 Update Impacting the Debate Moderator: Dr. Duncan A. N. Emerton Managing Consultant DATAMONITOR HEALTHCARE CONSULTING Panelists: Patrick Vink, Senior Vice President, Global Head of Biologics MYLAN James Harris Vice President AS BIOTECH AG Additional speakers to be announced.
9:45	Morning Refreshment and Networking Break
10:00	WALL STREET ADDRESS: Changes, Opportunity and Outlook for the Generics Industry Randall Stanicky Vice President, Global Investment Research GOLDMAN SACHS
10:30	Globalization, Mergers & Acquisitions Vijay Karwal Managing Director, Healthcare ABN AMRO/RBS
11:00	2008 US Strategic Management Review: Trends, Issues, Outlook Douglas M. Long Vice President, Industry Relations IMS HEALTH, INC
11:30	Q&A with GOLDMAN SACHS, ABN AMRO/RBS and IMS HEALTH
12:00	Luncheon for Delegates and Speakers
1:00	A Dickensian View of Pharmaceutical Antitrust: Bleak House or Great Expectations? David Balto, Attorney-at-Law Former Assistant Director for Policy and Evaluation FEDERAL TRADE COMMISION, BUREAU OF COMPETITION Meredyth Smith Andrus Attorney, Health Care Services and Products Division FEDERAL TRADE COMMISION, BUREAU OF COMPETITION
1:45	Patent Reform: A Generic Industry Friend or Foe Beverly W. Lubit, Esq, PhD Partner, Intellectual Property Practice Group WOLF, BLOCK, SCHORR & SOLIS-COHEN LLP
2:30	EXECUTIVE ROUNDTABLE: The Changing Competitive Landscape of the Generic Drugs Industry Moderator: Vijay Karwal Managing Director, Healthcare ABN AMRO/RBS Panelists: Kurt Orlorski President WOCKHARDT USA Vince Kaiman, Vice President and General Manager, COVIDIEN Mallinckrodt Pharmaceuticals Additional panelists to be announced.
3:15	Networking and Refreshment Break
3:30	UP-TO-THE-MINUTE ANALYSIS: Recent Court Decisions Affecting the Generic Drug Industry Michael J. Gaertner, Partner LOCKE LORD BISSELL & LIDDELL LLP
4:15	Understanding the 180-Day Exclusivity Forfeiture Provisions of the MMA Aaron F. Barkoff Partner MCDONNELL BOEHNEN HULBERT & BERGHOFF LLP
5:00	Day One Concludes